Erschienen in:

01.04.2014 | Erratum

Erratum to: Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

verfasst von: Yu Sunakawa, Junji Furuse, Takuji Okusaka, Masafumi Ikeda, Fumio Nagashima, Hideki Ueno, Shuichi Mitsunaga, Kensei Hashizume, Yuichiro Ito, Yasutsuna Sasaki

Erschienen in: Investigational New Drugs | Ausgabe 2/2014